PSMA PET/CT using short-lived radionuclides, as, e.g., gallium-68 (half-life: 68 min) in the form of [68Ga]Ga-PSMA-11 has shown a high sensitivity for tumor localization in the BCR setting [3,4]. This evidence concerns the gene FOLH1 and neoplasm.